Skip to main navigation
Logo
  • Careers
  • Contact
  • Home
  • Company
    • Founder's Story
    • Senior Management
    • Board of Directors
  • Products
    • Overview
    • SUFENTANIL
    • DSUVIA
    • DZUVEO
    • Zalviso US
    • Zalviso EU
  • Partnering
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Shareholder Services
  • Media
    • Overview
    • Press Releases
    • Publications
  • Military
  • Careers
  • Contact

Investors

Contents

News Releases

Keyword search

3/21/2023
AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023
3/14/2023
AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals
3/1/2023
AcelRx Pharmaceuticals Announces Peer-Reviewed Publication On the Use of DSUVIA® For In-Office Rhinology Procedures
  • Print Page
  • RSS Feeds
  • Overview
  • News & Events
    • News Releases
    • Upcoming Events
    • Past Events
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Shareholder Services
  

© 2023 AcelRx Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy | Terms of Use | CA state requirements